The abstract is read at the publisher; the summary is JClub's.
MRI-derived proton density fat fraction and proton magnetic resonance spectroscopy quantify hepatic lipid content in MASLD with high sensitivity and specificity, including at low fat fractions.
- Why it matters: Biopsy is the gold standard for MASLD staging but is invasive; non-invasive imaging is needed to diagnose steatosis and assess fibrosis and inflammation more safely.
- What they did: The review evaluates established and emerging imaging methods, comparing ultrasound, quantitative ultrasound, transient elastography, CT, MRI fat quantification, elastography, and nuclear imaging, emphasizing measurement principles and practical limits.
- The result: It concludes that multiparametric, multimodal imaging—integrating quantitative biomarkers with clinical and biochemical data—could improve risk stratification and treatment monitoring, though many advanced techniques remain research-only.
The findingWhy it mattersWhat they didThe result
AI summary of the abstract · may contain errors · not medical advice · read the paper.